News
Hikma launches generic Advair Diskus® following FDA approval
News
Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA
News
Hikma launches Icosapent Ethyl Capsules
Our impact
The impact we have on people’s lives is important, positive and far-reaching. Watch this short video to learn about how we supported the treatment of refugees suffering from sickle cell anemia in Lebanon through our donation of critical medicines.
#OwnYour Career @Hikma
Meet Basel, Sales and Marketing Manager at our Iraq site and discover why he loves working at Hikma
Case study
Our support and impact; improving patient’s access to ritonavir
Insight
Kept out of reach - tackling the enduring challenge of access to medicine
Update
Hikma update regarding COVID-19
Find out more
Who we are. We make high quality medicines and make them accessible to the people that need them.
News
Hikma continues strong 2020 performance and updates full year guidance
Find out more
Our commitment to sustainability
Find out more
We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.